MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Bilateral vestibulopathy due to neurosarcoidosis mimicking Parkinsonian syndrome

    M. Hamaguchi, H. Fujita, K. Suzuki (Utsunomiya, Japan)

  • Biomarkers of idiopathic REM sleep behavior disorder versus RBD within narcolepsy

    E. Antelmi, F. Pizza, Y. Sosero, V. Donadio, A. Incensi, R. Liguori, G. Plazzi (Bologna, Italy)

  • Biomarkers of the Level of Cognitive Impairment (CI) in patients with Parkinson’s Disease (PD): MRS study

    I. Karaban', N. Karasevich, Z. Rozhkova (Kyiv, Ukraine)

  • Biphasic Dyskinesias in Parkinson’s disease Patients treated with Levodopa/Carbidopa Intestinal Gel: Insights from a Multicenter Retrospective Analysis

    M. Marano, T. Naranian, L. Di Biase, A. Di Santo, R. Arca, G. Cossu, P. Marano, V. Di Lazzaro, A. Fasano (Rome, Italy)

  • Bladder Training for Urinary Tract Symptoms in PD – A Randomised Controlled Trial

    C. Mcdonald, J. Rees, K. Winge, J. Newton, D. Burn (Gateshead, United Kingdom)

  • Blood brain barrier dysfunction cause idiopathic adult onset ventriculomegaly?

    E. Oh, H. Chang, S. Kim, S. Kim, J. Heo (Daejeon, Republic of Korea)

  • Blood Metagenomics Analyses of Brazilian Parkinson’s Disease Patients: A Clinical Substype Study

    G. Poralla, V. Rayol, N. Woldmar, B. Fadel, L. Giacomin, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

  • Blood–brain barrier breakdown in an adult mouse model of Parkinson’s disease

    E. Del-Bel, F. Grano (Ribeirão Preto, Brazil)

  • Blue light therapy glasses in Parkinson’s disease: patients’ experience and effectiveness

    K. Smilowska, D. van Wamelen, A. Schoutens, M. Meinders, B. Bloem (Nijmegen, Netherlands)

  • BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

    Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley